Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne L Taylor

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Congestive Heart Failure (Greenwich, Conn.)|October 8, 2004
Endothelial dysfunction and nitric oxide enhancing therapy: a new approach to the treatment of heart failureAnne L Taylor
Heart Failure Clinics|March 13, 2012
Nitric oxide modulation as a therapeutic strategy in heart failureAnne L Taylor
Circulation|February 13, 2015
Racial differences and racial disparities: the distinction mattersAnne L Taylor
Circulation. Heart Failure|February 13, 2016
Making Medicine Precise and Personalized: What Can We Learn from the Past?Anne L Taylor
The American Journal of Cardiology|October 18, 2005
The African American Heart Failure Trial: a clinical trial updateAnne L Taylor
Journal of Cardiac Failure|October 30, 2003
The African-American Heart Failure Trial (A-HeFT): rationale and methodologyAnne L Taylor
Archives of Disease in Childhood. Education and Practice Edition|March 1, 2012
Best practice in substance misuseAnne L Taylor
Current Heart Failure Reports|January 31, 2015
Heart failure in womenAnne L Taylor
Cleveland Clinic Journal of Medicine|March 23, 2007
Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failureMonica Colvin-Adams, Anne L Taylor
Circulation|December 7, 2005
Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Anne L Taylor, Jackson T Wright
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Congestive Heart Failure (Greenwich, Conn.)|October 8, 2004
Endothelial dysfunction and nitric oxide enhancing therapy: a new approach to the treatment of heart failureAnne L Taylor
Heart Failure Clinics|March 13, 2012
Nitric oxide modulation as a therapeutic strategy in heart failureAnne L Taylor
Circulation|February 13, 2015
Racial differences and racial disparities: the distinction mattersAnne L Taylor
Circulation. Heart Failure|February 13, 2016
Making Medicine Precise and Personalized: What Can We Learn from the Past?Anne L Taylor
The American Journal of Cardiology|October 18, 2005
The African American Heart Failure Trial: a clinical trial updateAnne L Taylor
Journal of Cardiac Failure|October 30, 2003
The African-American Heart Failure Trial (A-HeFT): rationale and methodologyAnne L Taylor
Archives of Disease in Childhood. Education and Practice Edition|March 1, 2012
Best practice in substance misuseAnne L Taylor
Current Heart Failure Reports|January 31, 2015
Heart failure in womenAnne L Taylor
Cleveland Clinic Journal of Medicine|March 23, 2007
Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failureMonica Colvin-Adams, Anne L Taylor
Circulation|December 7, 2005
Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Anne L Taylor, Jackson T Wright
Pageof 6